Literature DB >> 2896888

Necrotising myopathy and zidovudine.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2896888

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  AIDS and the lung. 2--Antiretroviral treatment in human immunodeficiency virus disease.

Authors:  A J Pinching
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

Review 2.  Zidovudine (Retrovir) update.

Authors:  A R Rachlis
Journal:  CMAJ       Date:  1990-12-01       Impact factor: 8.262

Review 3.  Neuromuscular complications of human immunodeficiency virus infection and antiretroviral therapy.

Authors:  R G Miller
Journal:  West J Med       Date:  1994-05

Review 4.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

5.  Remarkable improvement of neuropsychiatric symptoms in HIV-infected patients after AZT therapy.

Authors:  M Hollweg; R R Riedel; F D Goebel; U Schick; D Naber
Journal:  Klin Wochenschr       Date:  1991-06-18

Review 6.  Didanosine, a new antiretroviral drug. A review.

Authors:  R M Franssen; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

7.  Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.

Authors:  H Manji; M J Harrison; J M Round; D A Jones; S Connolly; C J Fowler; I Williams; I V Weller
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.